No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Creo Medical Group announced an extension to the closing date for its retail offer on Friday, allowing existing retail shareholders more time to participate.
The AIM-traded firm said the new deadline was now set for 1630 BST on 17 October, extended from the previous closing date of 7 October.
It said there were no other changes to the overall timetable, with applications already made still valid and binding.
The revised schedule included key dates such as the receipt of proxy forms and CREST voting instructions by 1000 BST on 16 October, followed by the closing of the retail offer on 17 October.
Creo said the general meeting would take place at 1000 BST on 18 October, with the results of the meeting announced on the same day.
Trading of the new shares on AIM was expected to start on 21 October, with CREST accounts credited and share certificates dispatched by 3 November where applicable.
At 1551 BST, shares in Creo Medical Group were down 2% at 22p.
Reporting by Josh White for Sharecast.com.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.
